Exact Sciences (EXAS) Enterprise Value (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Enterprise Value data on file, last reported at -$964.7 million in Q4 2025.

• Enterprise Value for Q4 2025 came in at -$964.7 million, up 7.06% year-over-year; the trailing twelve-month figure through Dec 2025 was -$964.7 million (up 7.06% YoY), and the FY2025 annual result was -$964.7 million, up 7.06% from the prior year.
• Enterprise Value climbed to -$964.7 million in Q4 2025 per EXAS's latest filing, from -$1.0 billion in the prior quarter.
• Over five years, Enterprise Value peaked at -$213.0 million in Q2 2025 and troughed at -$1.4 billion in Q1 2021.
• A 5-year average of -$869.6 million and a median of -$801.6 million in 2022 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value tumbled 39.04% in 2024, then soared 77.5% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$1.0 billion in 2021, then surged by 38.66% to -$632.1 million in 2022, then retreated by 23.03% to -$777.6 million in 2023, then sank by 33.48% to -$1.0 billion in 2024, then advanced by 7.06% to -$964.7 million in 2025.
• Business Quant data shows EXAS's Enterprise Value at -$964.7 million in Q4 2025, -$1.0 billion in Q3 2025, and -$213.0 million in Q2 2025.